Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Uterine fibroid polygenic risk score (PRS) associates and predicts risk for uterine fibroid
by
Roden, Dan
, Torstenson, Eric S
, Pendergrass, Sarah A
, Dikilitas, Ozan
, Hellwege, Jacklyn N
, Denny, Josh C
, Kullo, Iftikhar J
, Lee, Ming Ta Michael
, Edwards, Todd L
, Jarvik, Gail P
, Piekos, Jacqueline A
, Zhang, Yanfei
, Schaid, Daniel J
, Crosslin, David R
, Velez Edwards, Digna R
in
Electronic medical records
/ Fibroids
/ Genome-wide association studies
/ Linkage disequilibrium
/ Phenotypes
/ Tumors
/ Uterus
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Uterine fibroid polygenic risk score (PRS) associates and predicts risk for uterine fibroid
by
Roden, Dan
, Torstenson, Eric S
, Pendergrass, Sarah A
, Dikilitas, Ozan
, Hellwege, Jacklyn N
, Denny, Josh C
, Kullo, Iftikhar J
, Lee, Ming Ta Michael
, Edwards, Todd L
, Jarvik, Gail P
, Piekos, Jacqueline A
, Zhang, Yanfei
, Schaid, Daniel J
, Crosslin, David R
, Velez Edwards, Digna R
in
Electronic medical records
/ Fibroids
/ Genome-wide association studies
/ Linkage disequilibrium
/ Phenotypes
/ Tumors
/ Uterus
2022
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Uterine fibroid polygenic risk score (PRS) associates and predicts risk for uterine fibroid
by
Roden, Dan
, Torstenson, Eric S
, Pendergrass, Sarah A
, Dikilitas, Ozan
, Hellwege, Jacklyn N
, Denny, Josh C
, Kullo, Iftikhar J
, Lee, Ming Ta Michael
, Edwards, Todd L
, Jarvik, Gail P
, Piekos, Jacqueline A
, Zhang, Yanfei
, Schaid, Daniel J
, Crosslin, David R
, Velez Edwards, Digna R
in
Electronic medical records
/ Fibroids
/ Genome-wide association studies
/ Linkage disequilibrium
/ Phenotypes
/ Tumors
/ Uterus
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Uterine fibroid polygenic risk score (PRS) associates and predicts risk for uterine fibroid
Journal Article
Uterine fibroid polygenic risk score (PRS) associates and predicts risk for uterine fibroid
2022
Request Book From Autostore
and Choose the Collection Method
Overview
Uterine fibroids (UF) are common pelvic tumors in women, heritable, and genome-wide association studies (GWAS) have identified ~ 30 loci associated with increased risk in UF. Using summary statistics from a previously published UF GWAS performed in a non-Hispanic European Ancestry (NHW) female subset from the Electronic Medical Records and Genomics (eMERGE) Network, we constructed a polygenic risk score (PRS) for UF. UF-PRS was developed using PRSice and optimized in the separate clinical population of BioVU. PRS was validated using parallel methods of 10-fold cross-validation logistic regression and phenome-wide association study (PheWAS) in a seperate subset of eMERGE NHW females (validation set), excluding samples used in GWAS. PRSice determined pt < 0.001 and after linkage disequilibrium pruning (r2 < 0.2), 4458 variants were in the PRS which was significant (pseudo-R2 = 0.0018, p = 0.041). 10-fold cross-validation logistic regression modeling of validation set revealed the model had an area under the curve (AUC) value of 0.60 (95% confidence interval [CI] 0.58–0.62) when plotted in a receiver operator curve (ROC). PheWAS identified six phecodes associated with the PRS with the most significant phenotypes being 218 ‘benign neoplasm of uterus’ and 218.1 ‘uterine leiomyoma’ (p = 1.94 × 10–23, OR 1.31 [95% CI 1.26–1.37] and p = 3.50 × 10–23, OR 1.32 [95% CI 1.26–1.37]). We have developed and validated the first PRS for UF. We find our PRS has predictive ability for UF and captures genetic architecture of increased risk for UF that can be used in further studies.
Publisher
Springer Nature B.V
This website uses cookies to ensure you get the best experience on our website.